|1.||Chu, Nai-hui: 2 articles (10/2013 - 12/2008)|
|2.||Yilmaz, A: 1 article (01/2016)|
|3.||Bolukbasi, O: 1 article (01/2016)|
|4.||Gualano, G: 1 article (12/2015)|
|5.||Dedicoat, M: 1 article (12/2015)|
|6.||Muylle, I: 1 article (12/2015)|
|7.||Duarte, R: 1 article (12/2015)|
|8.||Tiberi, S: 1 article (12/2015)|
|9.||Günther, G: 1 article (12/2015)|
|10.||TBNET: 1 article (12/2015)|
|1.||Leprosy (Hansen's Disease)
01/05/2016 - "Prothionamide (PTH) is the secondary drug used against Mycobacterium tuberculosis bacteria and leprosy. "
01/01/1985 - "Prothionamide and dapsone therapy in leprosy--a clinical study."
10/01/1986 - "In Guadeloupe, from January 1980 to December 1984, 420 leprosy patients were put under daily multidrug therapy: 10 mg/kg RMP plus 100 mg DDS during six months for paucibacillary patients, 10 mg/kg RMP plus 100 mg DDS during 24 months supplemented during the 12 first months with 10 mg/kg of a thioamide, ethionamide or protionamide, for multibacillary patients. "
09/01/1984 - "Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy."
09/01/1981 - "Prothionamide and prothionamide-S-oxide in experimental leprosy."
12/01/1970 - "[Clinico-radiological observations and biological studies in patients with pulmonary tuberculosis treated with prothionamide]."
05/01/1972 - "[Protionamide in the treatment of pulmonary tuberculosis]."
01/01/1971 - "[Use of prothionamide in the treatment of pulmonary tuberculosis]."
01/01/1971 - "[Use of prothionamide in the treatment of patients with pulmonary tuberculosis]."
05/01/1976 - "[Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method]."
11/01/1968 - "[Clinical study of prothionamide (1321 Th) administered by venous route in treatment of tuberculosis. "
01/01/1972 - "[Action of protionamide on tuberculosis mycobacteria in vitro]."
05/01/1970 - "[Prothionamide in the combination therapy of tuberculosis]."
12/01/2010 - "Seven of these 44 patients (15.9%) developed hepatitis after being treated with prothionamide concurrent with other anti-tuberculosis agents. "
09/01/1968 - "Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials."
03/01/2006 - "A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy."
01/01/1985 - "Combined therapy with prothionamide and dapsone was instituted in fifteen active untreated lepromatous leprosy cases for a period of 18 months. "
03/01/1984 - "The implications of these findings for the use of ethionamide or prothionamide in the treatment of lepromatous leprosy are discussed."
03/01/2006 - "In 1982-1984 we conducted a six-month clinical trial in 50 previously untreated lepromatous leprosy patients randomly assigned to directly observed monotherapy with one of two thioamides, ethionamide or prothionamide, each given six times a week at doses of either 250 mg or 500 mg. The findings of this study have only recently been analyzed, and the potential for the use of these thioamides in leprosy patients placed in perspective. "
|5.||Extensively Drug-Resistant Tuberculosis
08/01/2012 - "A number of recent studies revealed that successful treatment of the patients with MDR/XDR- TB was not achieved due to high resistant rates to many second-line drugs such as kanamycin and prothionamide including poor adherence of the lengthy treatment. "
12/01/2015 - "Resistance to prothionamide/ethionamide was high in bacilli from pre-XDR-TB patients (43%) and XDR-TB patients (49%). "
|9.||Streptomycin (Streptomycin Sulfate)
|1.||Drug Therapy (Chemotherapy)